Relation of B-Type Natriuretic Peptide Early After Acute Myocardial Infarction to Left Ventricular Diastolic Function and Extent of Myocardial Damage Determined by Magnetic Resonance Imaging

American Journal of Cardiology

Volumn 97, Issue 8, 2006, Pages 1146-1150

  Paelinck, Bernard P ^a   Vrints, Christiaan J ^a   Bax, Jeroen J ^b   Bosmans, Johan M ^a   De Hert, Stefan G ^a   de Roos, Albert ^b   Lamb, Hildo J ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIASTOLE; FEMALE; FUNCTIONAL ASSESSMENT; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEART VENTRICLE SEPTUM; HUMAN; MALE; MITRAL VALVE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SCAR;

BLOOD FLOW VELOCITY; CONTRAST MEDIA; DIASTOLE; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MITRAL VALVE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645730222     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.030     Document Type: Article

References (20)

1. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
2. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
3. Paelinck B.P., de Roos A., Bax J.J., Bosmans J.M., van der Geest R.J., Dhondt D., Parizel P.M., Vrints C.J., and Lamb H.J. Feasibility of tissue magnetic resonance imaging. a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45 (2005) 1109-1116
4. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., Verani M.S., and American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
5. Kellman P., Arai A.E., McVeigh E.R., and Aletras A.H. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47 (2002) 372-383
6. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., and Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
7. Kaandorp T.A., Bax J.J., Lamb H.J., Viergever E.P., Boersma E., Poldermans D., van der Wall E.E., and de Roos A. Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?. Am J Cardiol 95 (2005) 925-929
8. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., and Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
9. Mega J.L., Morrow D.A., de Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., Gibson C.M., Antman E.M., and Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 44 (2004) 335-339
10. Flacke S.J., Fischer S.E., and Lorenz C.H. Measurement of gadopentetate dimeglumine partition coefficient in human myocardium in vivo. normal distribution and elevation in acute and chronic infarction. Radiology 218 (2001) 703-710
11. Cochet A., Zeller M., Cottin Y., Robert-Valla C., Lalande A., L'Huillier I., Comte A., Walker P.M., Desgres J., Wolf J.E., and Brunotte F. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail 6 (2004) 555-560
12. Bassan R., Potsch A., Maisel A., Tura B., Villacorta H., Nogueira M.V., Campos A., Gamarski R., Masetto A.C., and Moutinho M.A. B-type natriuretic peptide. a novel marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 26 (2005) 234-240
13. Jernberg T., Lindahl B., Siegbahn A., Andren B., Frostfeldt G., Lagerqvist B., Stridsberg M., Venge P., and Wallentin L. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 42 (2003) 1909-1916
14. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., Fuchtbauer E.M., Dohrmann U., Beyersdorf F., Radicke D., and Holubarsch C.J. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium. influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
15. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., Nishino K., Yoshimasa T., and Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
16. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., Masuda I., Nakanishi K., Yoshimasa T., and Hashimoto. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
17. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., and Maisel A.S. Utility of B-natriuretic peptide in detecting diastolic dysfunction. comparison with Doppler velocity recordings. Circulation 105 (2002) 595-601
18. Yu C.M., Sanderson J.E., Shum I.O., Chan S., Yeung L.Y., Hung Y.T., Cockram C.S., and Woo K.S. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with restrictive filling pattern. Eur Heart J 17 (1996) 1694-1702
19. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., and Tajik A.J. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
20. Dokainish H., Zoghbi W.A., Lakkis N.M., Quinones M.A., and Nagueh S.F. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93 (2004) 1130-1135